GlassScriptPhysician profile
Brian A Padgham
NPI 1073611505
$3,382.61
in general payments reported to CMS, 2019-2025
14 companies · $563 in 2025
The $563 reported for 2025 was more than what 80% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $580 · 2020: $67.22 · 2021: $176 · 2022: $603 · 2023: $543 · 2024: $851 · 2025: $563.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,756 · Entertainment: $200.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,756.38 |
| Entertainment | $200.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,291.39 | 2019-2025 | Total30, Precision 1, Dailies |
| Bausch & Lomb Americas INC. | $527.00 | 2022-2025 | Infuse, Biotrue One Day |
| Coopervision INC. | $460.13 | 2019-2024 | Myday Contact Lens |
| Optos, INC. | $281.69 | 2022-2025 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Glaukos Corporation | $141.90 | 2019 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $141.39 | 2019 | |
| Lkc Technologies, INC. | $140.47 | 2024-2025 | |
| Abbvie INC. | $98.86 | 2022-2023 | |
| Abb Con-Cise Optical Group LLC | $78.34 | 2019-2025 | Contact Lens, Spectacle Lenses |
| Johnson & Johnson Vision Care, INC. | $67.90 | 2021-2022 | |
| Allergan, INC. | $67.41 | 2022 | |
| Lombart Brothers, INC. | $34.48 | 2025 | Opd-III |
| Dompe US, INC. | $26.70 | 2024 | Oxervate |
| Shire North American Group INC | $24.95 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Padgham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.